On 23 October 2020, Cambodia entered into a Memorandum of Understanding (MOU) with the United States to cooperate on patents. While the details have not been released at time of writing, it is expected that this MOU will be aligned in its key aspects with some of Cambodia’s existing patent agreements with other jurisdictions.
This provides for an accelerated patent decision under the Patent Recognition Program (PRP) provided the following criteria are met:
Provided all the requirements are met, the Cambodian Ministry of Industry and Handicrafts (MIH) will deliver an accelerated patent decision within three months from the date of requesting the PRP.
This provides for a re-registration of granted Singapore patents. The important features are:
This provides for an accelerated patent decision under the Patent Recognition Program (PRP) provided the following criteria are met:
Provided all the requirements are met, the Cambodian Ministry of Industry and Handicrafts (MIH) will deliver an accelerated patent decision within three months from the date of requesting the PRP.
This provides for the validation in Cambodia of a patent granted by the European Patent Office (EPO). It is required that an applicant file a request for validation and pay the relevant fee within six months of the date of publication of the European search report or, where applicable, within the period for performing the acts required for an international application's entry into the European phase.
Once a European patent is granted, validation follows the usual EPO procedures. In particular, the claims must be translated into Khmer and filed within three months of the date of publication of the European patent grant.
Patents may only be validated in relation to subject matter that is patentable in Cambodia.
This provides for a validation of granted Chinese patents. The important features are:
Cambodia is designated by the World Trade Organisation as a Least Developed Country (LDC) under the TRIPS agreement. The LDC designation permits Cambodia to exclude all pharmaceuticals from patent protection. Currently, this exemption applies until 2033.
In settling important patent cooperation agreements with Singapore, China, South Korea, Japan, Europe and now the US, the Cambodian Government has demonstrated its commitment to promoting and encouraging investment in innovation.
While we wait for details of the implementation of the Cambodia-US MOU, US based applicants and patentees are well advised to take notice of this important development, especially if the implementation is a validation or re-registration scheme as for China and Singapore.